Advertisement
Advertisement
U.S. Markets open in 2 hrs 16 mins
Advertisement
Advertisement
Advertisement
Advertisement

LENSAR, Inc. (LNSR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.6400-0.6100 (-18.77%)
At close: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.2500
Open3.4100
Bid1.4200 x 1100
Ask4.3300 x 1000
Day's Range2.6400 - 3.4100
52 Week Range2.1500 - 8.8000
Volume29,338
Avg. Volume22,349
Market Cap29.102M
Beta (5Y Monthly)-0.22
PE Ratio (TTM)N/A
EPS (TTM)-2.4480
Earnings DateMay 08, 2023 - May 12, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.00
  • Insider Monkey

    LENSAR, Inc. (NASDAQ:LNSR) Q4 2022 Earnings Call Transcript

    LENSAR, Inc. (NASDAQ:LNSR) Q4 2022 Earnings Call Transcript March 16, 2023 Operator: Good morning, and thank you for your participation. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. As a reminder, this conference call will be recorded. I would now like to turn the conference over […]

  • Business Wire

    LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

    ORLANDO, Fla., March 16, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter and full year ended December 31, 2022 and provided an update on key operational initiatives.

  • Business Wire

    LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023

    ORLANDO, Fla., March 09, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s fourth quarter and full year 2022 financial results will be released before market open on Thursday, March 16, 2023. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, March 16, 2023 to discuss the financial results

Advertisement
Advertisement